Provided by Tiger Trade Technology Pte. Ltd.

Tradr 2X Long SNPS Daily ETF

28.18
+1.636.14%
Post-market: 28.180.00000.00%19:39 EST
Volume:8.18K
Turnover:230.87K
Market Cap:1.83M
PE:- -
High:28.69
Open:28.00
Low:27.81
Close:26.55
52wk High:43.54
52wk Low:22.40
Shares:65.00K
Float Shares:45.00K
Volume Ratio:1.17
T/O Rate:18.18%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Company Profile

Company Name:
Tradr 2X Long SNPS Daily ETF
Exchange:
CBOE
Establishment Date:
2025
Employees:
- -
Office Location:
181 Westchester Avenue,Suite 402,Port Chester,New York,United States
Zip Code:
10573
Fax:
- -
Introduction:
Synaptogenix, Inc. operates as a biopharmaceutical company. It focuses on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease. The company is also evaluating therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as fragile X syndrome, multiple sclerosis, and niemann-pick type C disease. It has licensing agreements with Stanford University; Icahn School of Medicine; and The Board of Trustees of the Leland Stanford Junior University. The company was incorporated in 2012 and is based in New York, New York.